286
P.M. Vyas et al. / Biochemical Pharmacology 70 (2005) 275–286
[17] Reilly TP, Bellevue FH, Woster PM, Svensson CK. Comparison of the
in vitro cytotoxicity of hydroxylamine metabolites of sulfamethox-
azole and dapsone. Biochem Pharmacol 1998;55:803–10.
[18] Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK. A
role for bioactivation and covalent binding within epidermal kerati-
nocytes in sulfonamide-induced cutaneous drug reactions. J Invest
Dermatol 2000;114:1164–73.
[34] Medina L, Mills J, Leoung G, Hopewell P, Lee B, Modin G, et al. Oral
therapy for Pneumocystis carinii pneumonia in the acquired immu-
nodeficiency syndrome. NEJM 1990;323:776–82.
[35] Israili ZH, Cucinell SA, Vaught J, Davis E, Lesser JM, Dayton PG.
Studies of the metabolism of dapsone in man and experimental
animals: formation of N-hydroxy metabolites. J Pharmacol Exp Ther
1973;187:138–51.
[19] Reilly TP, Woster PM, Svensson CK. Methemoglobin formation by
hydroxylamine metabolites of sulfamethoxazole and dapsone: impli-
cations for differences in adverse drug reactions. J Pharmacol Exp
Ther 1999;288:951–9.
[36] Gordon GR, Murray JF, Peters JH, Gelber RH, Jacobson RR. Studies
on the urinary metabolites of dapsone in man. Inter
J Lepr
1979;47:681–2.
[37] Coleman MD, Scott AK, Breckenridge AM, Park BK. The use of
cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Br J Clin Pharmacol 1990;30:761–7.
[20] Shangari N, O’Brien PJ. The cytotoxic mechanism of glyoxal involves
oxidative stress. Biochem Pharmacol 2004;68:1433–42.
[21] Tafazoli S, O’Brien PJ. Prooxidant activity and cytotoxic effects of
indole-3-acetic acid derivatives radicals. Chem Res Toxicol
2004;17:1350–5.
[38] Cribb AE, Spielberg SP. Sulfamethoxazole is metabolized to
the hydroxylamine in humans. Clin Pharmacol Ther 1992;51:
522–6.
[22] Atsumi T, Ishihara M, Kadoma Y, Tonosaki K, Fujisawa S. Compara-
tive radical production and cytotoxicity induced by camphorquinone
and 9-fluorenone against human pulp fibroblasts. J Oral Rehabil
2004;31:1155–64.
[39] van der Ven AJ, Mantel MA, Vree TB, Koopmans PP, van der Meer
JW. Formation and elimination of sulphamethoxazole hydroxylamine
after oral administration of sulphamethoxazole. Br J Clin Pharmacol
1994;38:147–50.
[23] Yang J, Li H, Chen YY, Wang XJ, Shi GY, Hu QS, et al. Anthraqui-
nones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo
via reactive oxygen species-mediated dual regulation of apoptosis.
Free Radic Biol Med 2004;37:2027–41.
[40] van der Ven AJ, Vree TB, van Ewijk-Beneken Kolmer EW, Koopmans
PP, van der Meer JW. Urinary recovery and kinetics of sulphamethox-
azole and its metabolites in HIV-seropositive patients and healthy
volunteers after a single oral dose of sulphamethoxazole. Br J Clin
Pharmacol 1995;39:621–5.
[24] Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP. Reactions of the
nitroso and hydroxylamine metabolites of sulfamethoxazole with
reduced glutathione. Implications for idiosyncratic toxicity. Drug
Metab Dispos 1991;19:900–6.
[41] Vage C, Svensson CK. Evidence that the biotransformation of dapsone
and monoacetyldapsone to their respective hydroxylamine metabolites
in rat liver microsomes is mediated by cytochrome P450 2C6/2C11
and 3A1. Drug Metab Dispos 1994;22:572–7.
[25] Bradshaw TP, McMillan DC, Crouch RK, Jollow DJ. Formation of free
radicals and protein mixed disulfides in rat cells exposed to dapsone
hydroxylamine. Free Radic Biol Med 1997;22:1183–93.
[26] Vage C, Saab N, Woster PM, Svensson CK. Dapsone-induced hema-
tologic toxicity: comparison of the methemoglobin-forming ability of
hydroxylamine metabolites of dapsone in rat and human blood.
Toxicol Appl Pharmacol 1994;129:309–16.
[42] Carr A, Frei B. Does vitamin C act as a pro-oxidant under physio-
logical conditions? FASEB J 1999;13:1007–24.
[43] Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical
to biochemical mechanisms. Food Chem Toxicol 1999;37:949–62.
[44] Bolkenius FN, Grisar JM, DeJong W. A water-soluble quaternary
ammonium analog of alpha-tocopherol that scavenges lipoperoxyl,
superoxyl and hydroxyl radicals. Free Radic Res Commun
1991;14:363–72.
[27] Myhre O, Andersen JM, Aarnes H, Fonnum F. Evaluation of probes
20,70-dichlorofluorescin diacetate, luminol, and lucigenin as indicators
of reactive species formation. Biochem Pharmacol 2003;65:1575–82.
[28] Hempel SL, Buettner GR, O’Malley YQ, Wessels DA, Flaherty DM.
Dihydrofluorescein diacetate is superior for detecting intracellular
oxidants: comparision with 20,70-dichlorodihydrofluorescein diace-
tate, 5(and 6)-carboxy-20,70-dichlorodihydrofluorescein diacetate,
and dihydrorhodamine 123. Free Radic Biol Med 1999;27:146–59.
[29] Chignell CF, Sik RH. A photochemical study of cells loaded with 20,70-
dichlorofluoroscein: implications for detection of reactive oxygen
species generated during UVA irradiation. Free Radic Biol Med
2003;34:1029–34.
[45] Dinis TC, Maderia VM, Almeida LM, Bolkenius FN, Grisar JM,
DeJong W. Action of phenolic derivatives (acetaminophen, salicylate,
and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation
and as peroxyl radical scavengers. Arch Biochem Biophys
1994;315:161–9.
[46] Kang JO, Slivka A, Slater G, Cohen G. In vivo formation of hydroxyl
radicals following intragastric administration of ferrous salt in rats. J
Inorg Biochem 1989;35:55–69.
[47] Pedraza-Chaverri J, Barrera D, Maldonado PD, Chirino YI, Macias-
Ruvalcaba NA, Medina-Campos ON, et al. S-Allylmercaptocysteine
scavenges hydroxyl radical and singlet oxygen in vitro and attenuates
gentamicin-induced oxidative and nitrosative stress and renal damage
in vivo. BMC Clin Pharmacol 2004;4:5.
[30] Carr A, Tindall B, Penny R, Cooper DA. In vitro cytotoxicity as a
marker of hypersensitivity to sulphamethoxazole in patients with HIV.
Clin Exp Immunol 1993;94:21–5.
[31] Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M.
Metabolic predisposition to cutaneous adverse drug reactions. Role in
toxic epidermal necrolysis caused by sulfonamides and anticonvul-
sants. Arch Dermatol 1995;131:544–51.
[48] Juknat AA, Kotler ML, Quaglino A, Carrillo NM, Hevor T. Necrotic
cell death induced by delta-aminolevulinic acid in mouse astrocytes.
Protective role of melatonin and other antioxidants. J Pineal Res
2003;35:1–11.
[32] Reilly TP, MacArthur RD, Farrough MJ, Crane LR, Woster PM,
Svensson CK. Is hydroxylamine-induced cytotoxicity a valid marker
for hypersensitivity reactions to sulfamethoxazole in HIV-infected
individuals? J Pharmacol Exp Ther 1999;291:1356–64.
[49] Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z.
Melatonin as an antioxidant: biochemical mechanisms and pathophy-
siological implications in humans. Acta Biochim Pol 2003;50:1129–
46.
[33] Pertel P, Hirschtick R. Adverse reactions to dapsone in persons
infected with human immunodeficiency virus. Clin Infect Dis
1994;18:630–2.
[50] Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrara F, Martin V, et al.
Regulation of antioxidant enzymes: a significant role for melatonin. J
Pineal Res 2004;36:1–9.